Andrew Penn, RN, MS, NP, CNS, APRN-BC
Clinical Professor
University of California, San Francisco, School of Nursing
University of California, San Francisco
San Francisco, California
Charles Raison, MD
Professor
University of Wisconsin-Madison
University of Wisconsin-Madison
Madison, Wisconsin
The introduction of psychedelic assisted therapies (PAT) marks one of the most significant changes in available treatments for our patients. While much research has been conducted to get the treatments through the FDA, there is much that is still not known and will need to be considered when determining how to use these treatments. Complicating matters are the cultural and policy issues around psychedelics such as decriminalization and recreational use that may already be impacting our patients. This session, led by two expert researchers in the field, will attempt to disentangle these issues and prepare clinicians to thoughtfully deploy these treatments.